Influence of erythropoietin on cognitive performance during experimental hypoglycemia in patients with type 1 diabetes mellitus: a randomized cross-over trial.
The incidence of severe hypoglycemia in type 1 diabetes has not decreased over the past decades. New treatment modalities minimizing the risk of hypoglycemic episodes and attenuating hypoglycemic cognitive dysfunction are needed. We studied if treatment with the neuroprotective hormone erythropoieti...
Main Authors: | Peter Lommer Kristensen, Ulrik Pedersen-Bjergaard, Troels Wesenberg Kjær, Niels Vidiendal Olsen, Flemming Dela, Jens Juul Holst, Jens Faber, Lise Tarnow, Birger Thorsteinsson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3618268?pdf=render |
Similar Items
-
Effects of angiotensin II receptor blockade on cerebral, cardiovascular, counter-regulatory, and symptomatic responses during hypoglycaemia in patients with type 1 diabetes
by: Louise H Færch, et al.
Published: (2015-12-01) -
Cognitive performance, symptoms and counter-regulation during hypoglycaemia in patients with type 1 diabetes and high or low renin-angiotensin system activity
by: Thomas Høi-Hansen, et al.
Published: (2009-12-01) -
Differences in cortical and pituitary activity in response to hypoglycaemia and cognitive testing in healthy men with different basal activity of the renin-angiotensin system
by: Lise G Bie-Olsen, et al.
Published: (2010-09-01) -
Angiotensin-converting enzyme activity and cognitive impairment during hypoglycaemia in healthy humans
by: Ulrik Pedersen-Bjergaard, et al.
Published: (2008-03-01) -
Gustatory sweating in people with type 1 and type 2 diabetes mellitus: Prevalence and risk factors
by: Carina Kirstine Klarskov, et al.
Published: (2021-10-01)